A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
10.1136/ijgc-2020-001604
Saved in:
Main Authors: | Ngoi, Natalie YL, Heong, Valerie, Ow, Samuel, Chay, Wen Yee, Kim, Hee Seung, Choi, Chel Hun, Goss, Geraldine, Goh, Jeffrey C, Tai, Bee Choo, Lim, Diana G, Kaliaperumal, Nivashini, Au, Veonice B, Connolly, John E, Kim, Jae-Weon, Friedlander, Michael, Kim, Kidong, Tan, David SP |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Language: | English |
Published: |
BMJ PUBLISHING GROUP
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/177402 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Outcome of failure in clearing the oesophageal margin in total gastrectomy for adenocarcinoma.
by: Goh, H.S., et al.
Published: (2011) -
Dual-targeting dual-action platinum(IV) platform for enhanced anticancer activity and reduced nephrotoxicity
by: Babak, Maria V., et al.
Published: (2020) -
Novel 1,3,4-oxadiazole targets STAT3 signaling to induce antitumor effect in lung cancer
by: Malojirao, V.H., et al.
Published: (2021) -
Fluorescent nanogel of arsenic sulfide nanoclusters
by: Wang, J., et al.
Published: (2014) -
Osmium carbonyl clusters: A new class of apoptosis inducing agents
by: Kong, K.V., et al.
Published: (2014)